Assessing Efficacy of Cognitive Behavioral Therapy for Insomnia in the Oncology Population

Clin J Oncol Nurs. 2022 Jul 25;26(4):399-405. doi: 10.1188/22.CJON.399-405.

Abstract

Background:  Insomnia is highly prevalent among the oncology population, and it can affect quality of life for patients with cancer and survivors. Medications are a common treatment for insomnia. However, other treatment options, such as cognitive behavioral therapy, may also be effective.

Objectives:  This review analyzes the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) to treat insomnia comorbid with cancer or during survivorship.

Methods:  Based on a literature search, 19 articles identified CBT-I as a treatment for individuals diagnosed with cancer.

Findings:  Studies confirm that CBT-I is an effective treatment for insomnia experienced by cancer survivors. A variety of treatment models have been studied, such as group-based, web-based, and video formats, as well as telemedicine delivery. Treatment effectiveness varies depending on the CBT-I treatment model used.

Keywords: CBT-I; cancer; cognitive behavioral therapy for insomnia; insomnia.

Publication types

  • Review

MeSH terms

  • Cancer Survivors* / psychology
  • Cognitive Behavioral Therapy*
  • Humans
  • Neoplasms* / complications
  • Quality of Life
  • Sleep Initiation and Maintenance Disorders* / therapy
  • Treatment Outcome